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ABSTRACT 
3-Hydroxy-3-methylglutaryl Coenzyme A reductase (Hmg) catalyses the conversion of 
HMG CoA to mevalonic acid; the first step of the isoprenoid biosynthetic pathway. 
This pathway produces a wide variety of primary metabolites which are involved in 
many different cellular processes. Neotyphodium endophytes in association with the 
grass host are known to produce a range of secondary metabolites including the indole 
diterpenoids ( eg paxilline and lolitrem) and the ergopeptine alkaloids ( eg ergovaline ). 
Given that these pathways are upregulated in planta the availability of mevalonic acid, 
be it from fungal or plant source, will be important in controlling the levels of the 
different toxins synthesised. The aim of this work was to clone the fungal endophyte 
hmg and characterise the promoter to enable study of its regulation in planta via 
reporter gene studies. 
Using degenerate primers designed against conserved regions of other hmg genes a 359 
bp fragment was amplified from the Neotyphodium lolii isolate Lp 19, which grows in 
perennial ryegrass (Lolium perenne). DNA sequencing confirmed that the sequence 
amplified was part of a unique hmg gene. Southern hybridisations suggest that there is 
a single copy of hmg in strain Lp 19 ( a haploid) but two copies in strain Lp 1 ( an 
interspecific hybrid; Schardl et al. 1994). The fragment of N. lolii hmg was used to 
screen a 11,GEM- l 2 genomic library of Lp 19 and four positive overlapping clones were 
isolated. 
Fragments of one clone, AJD 12, were subcloned, sequenced and a physical map of this 
region of the genome was constructed. The entire sequence of hmg was determined 
using primer walking and was found to encode a 1188 amino acid polypeptide. From 
comparison to other Hmg proteins the catalytic domain has been shown to be highly 
conserved while the amino-terminal domain, containing transrnembrane regions is 
divergent with very little sequence similarity near the translation start site and promoter 
region. 
Using RT-PCR analysis the hmg gene was shown to consist of two open reading frames 
separated by a 73 bp intron. RT-PCR was also used to determine the location of the 
transcriptional start site and this is supported by the presence of putative CAAT and 
TAT A consensus sequences. With the promoter region identified and characterised 
further analysis of the regulation of hmg in planta can be undertaken. 
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Chapter 1 
INTRODUCTION 
1.1 GRASS ENDO PHYTES 
The filamentous fungi of the Ascomycete family Clavicipitaceae (tribe Balansieae) 
form symbiotic associations with grasses of the Pooideae subfamily. Epichloe 
endophytes are natural agents of biological protection, and infection can be important 
for fitness, competitiveness and persistence of their grass hosts under conditions of 
biotic or abiotic stress. These symbionts inhabit reproductive and aerial host tissue, 
growing as sparsely branched hyphae in intercellular spaces. Nutrients are absorbed by 
these organisms from freely available materials (Clay 1990). 
1.1.1 Life Cycle 
Neotyphodium (formerly Acremonium) endophytes are anamorphic (asexual) forms of 
the ascomycetous Epichloe spp. and share many features with them. Epichloe spp. are 
the causative agents of "choke" disease of grasses and can be seed transmitted when the 
"choke" stage is not exhibited. Chokes are sporogenous stromata produced in 
association with host inflorescences, preventing seed production by arresting 
development of the florets. At this stage, E. typhina can undergo sexual crosses, 
producing ascospores which are, presumably, capable of infecting new host plants. 
Following fertilisation of E. typhina stromata by conidia of the opposite mating type, 
perithecia develop on this structure and release haploid ascospores when mature. The 
ascospores germinate to produce phialides and conidia, which in tum germinate to 
produce hyphae and more conidiophores. After the last cycle of this conidiation, the 
mycelia are thought to infect the host via the stigmata, leaf stem stomata and/or 
ancillary buds. In addition, meristematic tissue must become infected for survival of 
the fungus (Siegel and Schardl 1991). It is this spore forming stage which the asexual 
endophytes lack. The life cycle of the Neotyphodium endophytes occurs within organs 
of the host grass without eliciting any symptoms of disease and the maternal-line 
transmission due to seed dissemination of the endophytes is a highly efficient process, 
removing the need for spore dissemination (Schardl and An 1993). 
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Genetic analysis based on isozyme profiles and DNA sequence comparisons supports 
the theory of being multiple evolutionary origins of the asexual endophytes from 
Epichloe species, and even isolates from the same grass species can show considerable 
genetic diversity. Perennial rye grass is a known host of three species or taxa in the 
Epichloif group. The two known taxa of asexual, seed-borne endophytes are 
Neotyphodium lolii (Latch et al. l 984) also classified as taxonomic grouping one from 
Lolium perenne (LpTG-1) and LpTG-2 (Christensen et al. 1993). LpTG-2 is a 
heteroploid derived from an interspecific hybridisation whose most likely ancestors 
were N. lolii and E. typhina (Schardl et al. 1994 ). 
Extensively studied grass-endophyte interactions include the tall fescue (Festuca 
arundinacea) and perennial ryegrass (Lolium perenne) with the endophytes 
Neotyphodium coenophialum and Neotyphodium lolii respectively. These two grass 
species are major forage crops in grazing agro-ecosystems, with endophyte infected 
ryegrass and tall fescue being widespread in New Zealand and the United States, 
respectively. The importance of the endophytes to these grasses has recently led to their 
intense investigation. 
1.1.2 Biological Benefits of Endophyte/Plant Interaction 
Endophytic fungi have dramatic effects on the physiology, ecology and reproductive 
biology of host plants. The presence of the endophyte increases drought tolerance and 
leads to changes of grass morphology, growth rate and growth yield. The production of 
toxic alkaloids enable endophytic fungi to defend their host against mammalian and 
insect herb ivory, and offers resistance to fungal pathogens and nematodes. This 
contributes to the excellent field persistence of these grasses with little metabolic cost to 
the plant (Clay 1990). 
Endophyte infection alters the host plant physiology, providing greater vegetative 
vigour. More inflorescences and seeds are produced and the seeds are able to germinate 
more rapidly, with faster growing seedlings. Infected seeds have a higher survival rate 
as they contain high concentrations of alkaloids and so are less likely to be eaten. 
Endophyte infected tall fescue has been found to maintain a higher productivity than 
uninfected plants under drought conditions. This is due to the infected plants 
maintaining a higher net photosynthetic rate, as well as having greater stomatal 
resistance (Clay 1990). 
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A number of alkaloids are produced by endophytes within plant tissues and these are 
active against insects , fungal pathogens, nematodes and mammals. These include 
peramine, ergovaline, lolines and the indole diterpenoids, paxilline and the lolitrems. 
The pyrrolizidine alkaloids (N-formyl loline and N-acetyl Joline), detected in A. 
coenophialum-infected tall fescue , are the most abundant secondary metabolites that 
have been identified and the most important bioprotective alkaloids known to be 
involved in many grass-endophyte associations. These compounds have been detected 
in very high levels in infected plants (> 0.8% plant dry weight) and have been shown in 
culture to be fungal metabolites (Wilkensen et al. 1997) . The production of these 
alkaloids is dependent on the fungal strain (Siegel et al. 1990) and are known to be 
potent insecticides. Their contribution to host fitness may be due to their ability to 
disrupt physiological processes controlled by biogenic arrunes (Scott and Schardl 1993). 
Peramine, a pyrrolopyrazine alkaloid, is produced by a number of endophytes including 
N. lolii , N. coenophialum and E. typhina strains. This is a potent insect feeding 
deterrent which is thought to be derived from proline and arginine. This alkaloid has 
been found to provide resistance to the Argentine stem weevil (Listronotus 
bonariensis) , a major pest of pastures in New Zealand. While the mechanism by which 
this is achieved remains unclear, the alkaloid has not been shown to be a mammalian 
toxin. Peramine has not been detected in fungal cultures or in uninfected plants, and 
therefore may be unique to the mutualistic association (Rowan and Gaynor 1986). 
Endophyte infection has also been shown to negatively influence populations of certain 
nematodes, thus offering the plant protection against nematode infection (Kimmons et 
al. 1990). There are contrasting reports regarding the effects of endophytes on plant 
parasitic nematodes but this variation in effect may reflect the relative sensitivities of 
different species to the toxins produced. Anti-fungal activity has also been reported in 
endophyte infected grasses. Resistance to pathogens has not been widely demonstrated, 
however isolation of endophytes which confer resistance to important fungal diseases 
would provide significant potential for improving the productivity of perennial ryegrass 
pastures (van Heeswijck and McDonald 1992). 
A. coenophialum infection of tall fescue produces ergopeptine alkaloids, in particular 
ergovaline, which is thought to be responsible for fescue toxicosis. Cattle grazing on 
infected tall fescue present a number of symptoms which are clinically identical with 
ergot poisoning. This condition is usually observed in summer, with cattle showing a 
range of symptoms which include, reduced weight gain, decreased milk production, 
lower feed intake, rough hair-coat, excessive salivation, increased respiration and high 
4 
temperatures. Fescue foot is another syndrome observed in cattle that have been 
feeding on infected tall fescue. This occurs most frequently in winter causing lameness 
and dry gangrene of extremities which can, in severe cases, lead to loss of hooves (van 
Heeswijck and McDonald 1992). The biochemical mechanisms responsible for these 
syndromes are not known, but the ergot alkaloids are known to interact with the a-
adreno and dopamine receptors in the brain, and these compounds have 
vascoconstrictive effects. Ergovaline is thought to be composed of a tricyclic peptide 
and an ergolene ring, synthes ised from the precursors mevalonic acid and tryptophan. 
Ergopeptines are found in a number of grass -endophyte interactions, including 
perennial ryegrass associations (Christensen er al. 1993). 
Cattle grazing on N. lolii infected perennial ryegrass suffer from the neurological 
disorder 'rye grass staggers'. The potent neurotoxin lolitrem A, and other indole 
diterpenoid lolitrems, have been isolated from perennial ryegrass (Lolium perenne) 
pastures on which this livestock disease occurs. These compounds have been shown to 
produce tremors in livestock and therefore may be the causative agents of the disease 
(Gallagher et al. 1982; Gallagher et al. 1981 ). These compounds are tremorgenic 
mycotoxins which are thought to bind to the GABAA receptor in the brain and inhibit 
its function (Gant et al. 1987), thus causing affected animals to display muscle spasms 
and a hypersensitivity to external stimuli. Little is known about the biochemical 
pathways leading to the synthesis of these compounds, although putative intermediates 
paxilline, paspaline and lolitriol have been identified and the outlines of a biosynthetic 
pathway suggested (Miles et al. 1992; Munday-Finch et al. 1996). Paxilline, a known 
tremorgen, is thought to be derived from tryptophan and mevalonic acid, and produced 
by a series of modifications of geranyl geranyl pyrophosphate. Cultures of N. lolii 
produce a reduced amount of lolitrem compared to amounts detected in planta, 
suggesting that the host plant may have a role in biosynthesis. 
Endophyte concentrations vary throughout the host plant, with higher concentrations of 
hyphae and metabolic activity in lower parts. Distribution is also high in the leaf sheath 
in comparison to the leaf blade. There are also concentration differences between 
leaves of different ages: younger leaves contain lower N. lolii concentrations, perhaps 
reflecting the pattern and stage of development of fungal and plant tissue (Herd et al. 
1997; Keogh et al. 1996). The distribution of alkaloids also varies throughout the host 
plant, with lolitrem B being present in higher concentrations in the leaf sheath than the 
blade and in particular, the outer leaf sheath. High lolitrem B concentrations have also 
been found in the older leaves, mostly in the upper portion of the leaf sheath, where the 
concentration of N. lolii was the highest. This distribution pattern correlates with 
livestock grazing patterns, the acquisition of the neurotoxin and development of 
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ryegrass staggers. Peramine was found in concentrations greater than the 10 ppm 
threshold which deters feeding by adult and larval Argentine stem weevil, in all 
portions of the grass except the tip of the older blades. As peramine is produced by N. 
lolii , it is apparent that this fungal metabolite may be mobile within the ryegrass tiller. 
Argentine stem weevil have been noted to often feed only on the top portion of ryegrass 
leaves , but it is not clear whether thi s behaviour is affected by the presence of N. lolii 
(Keogh et al. 1996). 
As the above compounds are not often detected in fungal culture or in endophyte free 
grass, it seems likely that molecular interactions occur between the grass host and 
endophytic fungus which result in the increased expression of these compounds within 
the symbiotic association. Thus these alkaloid production pathways provide an area for 
investigation into the symbiotic relationship between grasses and endophytes . The 
carbon skeleton for both indole diterpenoids, paxilline and lolitrem B , and the ergot 
alkaloid ergovaline, is derived from long chain isoprenoid units which are in turn 
derived from mevalonic acid. High level synthesis of these compounds with therefore 
be dependant on an abundant supply of mevalonic acid. The synthesis of mevalonic 
acid is catalysed by 3-hydroxy-3-methylglutaryl Coenzyme A reductase (Hrng); a key 
primary metabolic step in isoprenoid biosynthesis and therefore toxin production 
(Figure 1). 
1.2 HMG-CoA REDUCTASE 
3-Hydroxy-3-methylglutaryl Coenzyme A reductase (Hmg) catalyses the synthesis of 
the primary metabolite, mevalonic acid. This is the first step in the isoprenoid 
biosynthetic pathway which leads to intermediates that serve key roles in protein 
synthesis, protein glycosylation, electron transport, cell cycle control and maintenance 
of membrane fluidity. 
1.2.1 Structure and Function 
Eukaryotic Hmg is an integral membrane protein of the endoplasmic reticulum (ER). It 
is bound to the ER via an amino-terminal membrane domain which contains a number 
( 1-8) of hydrophobic regions or potential membrane spanning domains. A linker region 
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Figure 1 Biosynthesis of lolitrem B from acetyl CoA. 
The isoprenoid biosynthetic pathway produces essential primary metabolites which act as 
precursors for synthesis of secondary metabolites, not essential for basic function of the 
organism. Hmg converts Hmg CoA to mevalonate, a precursor for the diverse range of 
secondary metabolites produced via this pathway. The pathway for production of 
lolitrem B from geranyl geranyl pyrophosphate has not been elucidated, except for the 
two metabolites, paspaline and paxilline. 
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separates this domain from the carboxy-terminal domain, which contains the 
hydrophilic catalytic site which projects into the cytoplasm (Basson et al. 1988; Liscum 
et al. 1985). Mammalian Hmg is encoded by a si ngle gene, resulting in a single 
glycoprotein localised to the ER. In contrast, plants possess two or more isozymes of 
Hmg and these are encoded by small gene families. The activity of these enzymes is 
associated with plastid, mitochondrial and ER membranes. 
The am ino-terminal domain shows a low level of seq uence similarity between 
phylogenetic kingdoms. This membrane situated domain is complex and appears to 
consist of 7 or 8 transmembrane domains in yeast , animals and fungi (Basson et al. 
1988; Croxen et al. 1994; Liscum et al. 1985; Roitelman et al. 1992) in comparison 
with two domains in plants (Denbow et al. 1996; Enjuto et al. 1994). Despi te the lack 
of sequence conservation between organisms , thi s domain mediates important 
regulatory controls such as the stability of the protein (Gil et al. 1985; Kumagai et al. 
1995). 
In comparison, the amino acid sequence of the catalytic domain is conserved across 
eukaryotes, archaebacteria and eubacteria, suggesting it is under strong selective 
pressure (Lum et al. 1996). This domain catalyses the conversion of HMG CoA to 
mevalonate, the first committed step of the isoprenoid biosynthetic pathway. The 
crystal structure of Hmg from Pseudomonas mevalonii has been determined, showing 
Hmg to be a tightly bound dimer that brings together at the subunit interface the 
conserved residues implicated in substrate binding and catalysis. Regions have been 
identified that might be involved in the binding of Hmg-CoA as well as the reduced and 
oxidised forms of NAD(P) (Lawrence et al. 1995). A number of specific amino acid 
residues within the conserved catalytic domain are known to be required for catalysis 
and production of mevalonate; these include histidine, aspartate and glutamate residues 
(Bischoff and Rodwell 1997; Darnay et al. 1992; Frimpong and Rodwell 1994). 
Mevalonate provides a five-carbon building block for the synthesis of a wide and 
diverse range of products produced via this pathway (Goldstein and Brown 1990). 
Many essential primary metabolites are produced as well as secondary metabolites 
which are not essential for the functioning of the organism. 
1.2.2 Fungal Hmg 
The complete hmg gene has been isolated and characterised from the fungi Gibberella 
fujikuroi (Woitek et al. 1997) and Ustilago maydis (Croxen et al. 1994). G. fujikuroi is 
a rice pathogen which produces high levels of gibberellins, a family of diterpenoid plant 
hormones, while U. maydis is a pathogenic basidiomycete which induces tumours in 
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maize. The gene has also been studied in the yeasts Schizosaccharomyces pombe (Lum 
et al. 1996) and Saccharomyces cerevisiae (Basson et al. 1986). 
G. fitjikuroi contains only one hmg gene, encoding a predicted protein of 976 amino 
acids. This is somewhat smaller than other fungal Hmg polypeptides and Woitek et al. 
( 1997) determined this to be due to a shortened N-terminal domain . This truncated 
domai n has been determined to still contain seven putative transmembrane regions by 
the Kyte and Doolittle ( 1982) method. The G. fujikuroi hmg gene consists of a 2928 bp 
open reading frame which is interrupted by a putative 47 bp long intron. U. maydis 
appears to contain two structural genes encoding Hmg. Only one of these has been 
isolated and sequenced, and thi s was found to encode a 1165 amino acid polypeptide 
(Senstag et al. 1990). The N-terminal domain in U. maydis has been shown to contain 
eight putative hydrophobic domains, as determined by the Kyte and Doolittle (1982) 
method. Although, of these eight, only seven of these have been recognised as possible 
transmembrane regions. The U. maydis sequence does not possess any intronic regions 
and the position and presence of intrans does not appear to be conserved throughout 
eukaryotes. The catalytic domain of Hmg from another plant pathogenic fungus, 
Sphaceloma manihoticola has also been isolated and sequenced. It has been determined 
that this fungus also contains only one hmg gene (Woitek et al. 1997). 
S. pombe hmg encodes a predicted protein of 1053 amino acids and is considered to be 
intron free, as no intron consensus sequences have been located within the open reading 
frame. It is also predicted to contain eight transmembrane domains. S. cerevisiae has 
been found to possess two Hmg isozymes, each encoded by genes with single 
continuous open reading frames, 1054 amino acids for HMG 1 and 1045 amino acids for 
HMG2. 
Each of the Hmgs contain the recognised catalytically important histidine, aspartate and 
glutamate amino acid residues (Bischoff and Rodwell 1997; Darnay et al. 1992; 
Frimpong and Rodwell 1994) as well as the residues implicated in substrate binding 
(Lawrence et al. 1995). Of importance with respect to the regulation of Hmg activity is 
a serine located 6 residues downstream from the catalytically important histidine. This 
residue is present in each of the fungal Hmgs cloned to date and is known to be 
phosphorylated by an AMP-activated protein kinase, resulting in a loss of catalytic 
activity. The yeast Hmg peptides lack this regulatory serine residue and are therefore 
not regulated by phosphorylation at this position. 
10 
1.2.3 Regulation 
The compounds and enzymes of primary metabolism have essential roles in the survival 
of an organism. Intermediates of primary metabolic pathways often supply precursors 
of secondary metabolism, which give rise to compounds whose function is not essential. 
Therefore factors that influence primary metabolism will have some effect on secondary 
metabolism (Drew and Demain 1977). Primary metabolism is controlled by a number 
of mechanisms, including substrate induction, feedback repression and inhibition, 
catabolite repression and inhibition, and ATP regulation. In each case, regulation is a 
dynamic process dependent on the local concentration of effector molecules (Drew and 
Demain 1977). 
1.2.3.1 Regulation of Hmg 
In higher eukaryotes Hmg is considered to be the key regulatory enzyme of the 
isoprenoid biosynthetic pathway and as it is a typical housekeeping gene it is usually 
transcriptionally active. In mammals, Hmg activity can be regulated by feedback 
inhibition of steady state levels of Hmg mRNA, as well as at the molecular level to 
control the activity of the enzyme. This occurs by a coordinate modulation of synthesis 
of the protein when the pathway flux is low and degradation when the level of the 
pathway products are high. Regulation is therefore dependent on the concentration of 
an end-product. For regulation at both levels, two products of the terpenoid pathway 
are necessary: a sterol (low density lipoprotein) and a non-sterol product whose 
structural identity is yet to be determined. The amino-terminal anchor has been found 
to be necessary and sufficient to mediate the regulated degradation of Hmg in the 
endoplasmic reticulum (Hampton et al. 1996; Stermer et al. 1994 ). 
Hmg activity is also regulated by processes independent of the mevalonate pathway 
such as reversible phosphorylation. Enzyme activity is down-modulated due to 
phosphorylation by an AMP-activated protein kinase, which has no effect on the 
stability of the enzyme but instead alters the kinetics of the enzyme (Hampton et al. 
1996; Stermer et al. 1994) . Phosphorylation occurs at a serine located 6 residues from 
the catalytic histidine, a spacing that is conserved in the hmg of most eukaryotes 
(Friesen and Rodwell 1997). 
In plants, the number of genes encoding Hmg varies, depending on the species. 
Differential expression of the multiple hmg genes could play an important role in the 
regulation of enzyme activity. These hmg genes are also under a number of 
developmental and environmental regulatory mechanisms unique to plants, such as 
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light, phytohormones, pathogen attack, wounding, feedback mechanisms and 
endogenous protein factors. Much of the isoprenoid biosynthesis in plants is localised 
in specific compartments within a cell, which allows for the independent regulation of 
parallel pathways that produce different end products (Stermer et al. 1994 ). 
Regulation of Hmg activity in turn determines mevalonate production and thus the 
amount of end-products produced. 
1.3 AIMS AND BACKGROUND OF THIS STUDY 
Although filamentous fungal endophytes confer many beneficial properties onto their 
host, perennial ryegrass, the production of animal toxins is agriculturally undesirable for 
livestock. Genetic strategies are therefore being undertaken to manipulate fungal 
endophytes and their hosts for agricultural benefit. Mevalonic acid is a precursor of 
both paxilline and ergovaline and synthesis of this compound by Hmg is considered an 
important regulatory step. Therefore, disruption of the paxilline pathway could increase 
the pool of mevalonic acid available for ergovaline synthesis, due to continued 
expression of hmg. It is also possible that in the symbiotic association, the endophyte 
draws on mevalonic acid produced by the plant, and so does not use its own enzyme at 
all. This may still lead to an increased pool of mevalonic acid within the endophyte 
even if Hmg is tightly regulated. It is therefore important to understand how this gene 
is regulated in planta. The aim of this project was to clone the hmg gene from the 
haploid Neotyphodium isolate Lp19 (LpTG-1) (Christensen et al. 1993) and to identify 
the upstream regulatory region of this gene. The availability of these sequences will 
allow hmg expression to be determined in planta using a gus reporter gene construct. 
